Chris French
Directeur Technique/Scientifique/R&D chez CHECKMATE PHARMACEUTICALS, INC.
Profil
Chris French is currently the Vice President-Scientific Affairs at Checkmate Pharmaceuticals, Inc. She holds a Master's in Business Administration from St. Thomas University (Florida) and an undergraduate degree from the University of Mankato.
Postes actifs de Chris French
Sociétés | Poste | Début |
---|---|---|
CHECKMATE PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/07/2016 |
Formation de Chris French
University of Mankato | Undergraduate Degree |
St. Thomas University (Florida) | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |